PL320564A1 - Therapeutic set for treating osteoporosis - Google Patents

Therapeutic set for treating osteoporosis

Info

Publication number
PL320564A1
PL320564A1 PL95320564A PL32056495A PL320564A1 PL 320564 A1 PL320564 A1 PL 320564A1 PL 95320564 A PL95320564 A PL 95320564A PL 32056495 A PL32056495 A PL 32056495A PL 320564 A1 PL320564 A1 PL 320564A1
Authority
PL
Poland
Prior art keywords
treating osteoporosis
therapeutic set
therapeutic
osteoporosis
treating
Prior art date
Application number
PL95320564A
Inventor
Martine Gazard
Olivier Gros
Jacques Girard
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of PL320564A1 publication Critical patent/PL320564A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PL95320564A 1994-12-06 1995-12-05 Therapeutic set for treating osteoporosis PL320564A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9414630A FR2727629A1 (en) 1994-12-06 1994-12-06 OSTEOPOROSIS TREATMENT CYCLE KIT
PCT/FR1995/001596 WO1996017616A1 (en) 1994-12-06 1995-12-05 Kit for osteoporosis treatment cycle

Publications (1)

Publication Number Publication Date
PL320564A1 true PL320564A1 (en) 1997-10-13

Family

ID=9469504

Family Applications (1)

Application Number Title Priority Date Filing Date
PL95320564A PL320564A1 (en) 1994-12-06 1995-12-05 Therapeutic set for treating osteoporosis

Country Status (20)

Country Link
EP (1) EP0797444A1 (en)
JP (1) JPH10509729A (en)
KR (1) KR980700083A (en)
CN (1) CN1168634A (en)
AR (1) AR002946A1 (en)
AU (1) AU4307396A (en)
BR (1) BR9509961A (en)
CA (1) CA2207028A1 (en)
CZ (1) CZ175397A3 (en)
FI (1) FI972383A (en)
FR (1) FR2727629A1 (en)
HU (1) HUT77382A (en)
IL (1) IL116168A0 (en)
MA (1) MA23737A1 (en)
NO (1) NO972558L (en)
PL (1) PL320564A1 (en)
SK (1) SK68597A3 (en)
TR (1) TR199501530A1 (en)
WO (1) WO1996017616A1 (en)
ZA (1) ZA9510184B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
EP1880744B1 (en) 2002-05-10 2015-01-21 F.Hoffmann-La Roche Ag Bisphosphonic acids for the treatment and prevention of osteoporosis
ES2530791T3 (en) * 2002-12-20 2015-03-05 Hoffmann La Roche Ibandronate high dose formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE66608T1 (en) * 1984-04-30 1991-09-15 Procter & Gamble EQUIPMENT FOR THE TREATMENT OF OSTEOPOROSIS.
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
JP4481368B2 (en) * 1992-06-30 2010-06-16 味の素株式会社 Use of phosphonates for the treatment of osteoporosis
FR2694558B1 (en) * 1992-08-05 1994-10-28 Sanofi Elf Monohydrate of the disodium salt of 4-chlorophenylthiomethylene bisphosphonic acid, its preparation, the pharmaceutical compositions containing it.

Also Published As

Publication number Publication date
AR002946A1 (en) 1998-05-27
KR980700083A (en) 1998-03-30
FR2727629A1 (en) 1996-06-07
BR9509961A (en) 1997-11-25
HUT77382A (en) 1998-04-28
CZ175397A3 (en) 1997-10-15
EP0797444A1 (en) 1997-10-01
NO972558D0 (en) 1997-06-05
CN1168634A (en) 1997-12-24
MX9704105A (en) 1997-09-30
MA23737A1 (en) 1996-07-01
FI972383A0 (en) 1997-06-05
WO1996017616A1 (en) 1996-06-13
TR199501530A1 (en) 1996-10-21
CA2207028A1 (en) 1996-06-13
SK68597A3 (en) 1997-11-05
FR2727629B1 (en) 1997-02-28
JPH10509729A (en) 1998-09-22
IL116168A0 (en) 1996-01-31
ZA9510184B (en) 1996-06-11
NO972558L (en) 1997-08-05
AU4307396A (en) 1996-06-26
FI972383A (en) 1997-06-05

Similar Documents

Publication Publication Date Title
IL112455A0 (en) Combination treatment for osteoporosis
GB9407135D0 (en) Treatment of osteoporosis
GB2304196B (en) Electroconvulsive therapy
IL125493A0 (en) Combination therapy for osteoporosis
GB9421709D0 (en) Therapeutic compounds
IL114162A0 (en) Submersive therapy apparatus
GR3033744T3 (en) Therapeutic compounds
GB2288123B (en) Tumor treatment apparatus
IL115310A0 (en) Combination therapy for hypercholesterolemia
ZA9533B (en) Pentolifylline therapy
GB9410320D0 (en) Novel therapeutic method
IL120270A0 (en) Combination therapy to treat osteoporosis
IL136953A0 (en) Apparatus for therapeutic electromagnetic treatment
PL320564A1 (en) Therapeutic set for treating osteoporosis
GB2290452B (en) Shoe treatment apparatus
GB9416632D0 (en) Therapeutic compounds
GB9416629D0 (en) Therapeutic compounds
SI0769017T1 (en) Therapeutic compounds
GB9410775D0 (en) Treatment apparatus
GB9414242D0 (en) Therapeutic method
GB9411549D0 (en) Novel therapeutic method
GB9410319D0 (en) Novel therapeutic method
GB9410326D0 (en) Novel therapeutic method
GB9410693D0 (en) Novel therapeutic method